Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The BOD did take this up to $7.00 in the Mid 90's you know

I don't believe Swartz ever held anything close to half the stock. Care to share your calculations on this.

I believe Swartz the primary holder of the convertible warrants.Which is why the board had to issue the dividend to warrant holders also.


Share
New Message
Please login to post a reply